Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2

被引：31
作者：
Eloy, Philippine [1 ,2 ]
Solas, Caroline [3 ]
Touret, Franck [4 ]
Mentre, France [5 ]
Malvy, Denis [6 ,7 ]
de Lamballerie, Xavier [4 ]
Guedj, Jeremie [5 ]
机构：
[1] Nord Univ Paris, AP HP, Hop Bichat Claude Bernard, Dept Epidemiol Biostat & Rech Clin, Paris, France
[2] Inst Natl Sante & Rech Med INSERM, CIC EC 1425, Hop Bichat Claude Bernard, Paris, France
[3] Aix Marseille Univ, Hop La Timone, AP HM,Lab Pharmacocinet & Toxicol, Unite Virus Emergents UVE IRD 190 Inserm, Marseille, France
[4] Aix Marseille Univ, IRD 190 Inserm 1207 IHU Mediterranee Infect, Unite Virus Emergents, Marseille, France
[5] Univ Paris, IAME, INSERM, Paris, France
[6] Univ Hosp Ctr Bordeaux, Dept Infect & Trop Dis, Bordeaux, France
[7] Univ Bordeaux, Inserm 1219, Bordeaux, France
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 108卷 / 02期
关键词：
D O I：
10.1002/cpt.1877
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：188 / 188
页数：1
相关论文
共 5 条
[1]   Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection [J].
Du Yin-Xiao ;
Chen Xiao-Ping .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (02) :242-247
[2]   Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques [J].
Guedj, Jeremie ;
Piorkowski, Geraldine ;
Jacquot, Frederic ;
Madelain, Vincent ;
Thi Huyen Tram Nguyen ;
Rodallec, Anne ;
Gunther, Stephan ;
Carbonnelle, Caroline ;
Mentre, France ;
Raoul, Herve ;
de Lamballerie, Xavier .
PLOS MEDICINE, 2018, 15 (03)
[3]   Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea [J].
Sissoko, Daouda ;
Laouenan, Cedric ;
Folkesson, Elin ;
M'Lebing, Abdoul-Bing ;
Beavogui, Abdoul-Habib ;
Baize, Sylvain ;
Camara, Alseny-Modet ;
Maes, Piet ;
Shepherd, Susan ;
Danel, Christine ;
Carazo, Sara ;
Conde, Mamoudou N. ;
Gala, Jean-Luc ;
Colin, Geraldine ;
Savini, Helene ;
Bore, Joseph Akoi ;
Le Marcis, Frederic ;
Koundouno, Fara Raymond ;
Petitjean, Frederic ;
Lamah, Marie-Claire ;
Diederich, Sandra ;
Tounkara, Alexis ;
Poelart, Geertrui ;
Berbain, Emmanuel ;
Dindart, Jean-Michel ;
Duraffour, Sophie ;
Lefevre, Annabelle ;
Leno, Tamba ;
Peyrouset, Olivier ;
Irenge, Leonid ;
Bangoura, N'Famara ;
Palich, Romain ;
Hinzmann, Julia ;
Kraus, Annette ;
Barry, Thierno Sadou ;
Berette, Sakoba ;
Bongono, Andre ;
Camara, Mohamed Seto ;
Munoz, Valerie Chanfreau ;
Doumbouya, Lancine ;
Harouna, Souley ;
Kighoma, Patient Mumbere ;
Koundouno, Fara Roger ;
Lolamou, Rene ;
Loua, Cece Moriba ;
Massala, Vincent ;
Moumouni, Kinda ;
Provost, Celia ;
Samake, Nenefing ;
Sekou, Conde .
PLOS MEDICINE, 2016, 13 (03)
[4]   Favipiravir pharmacokinetics in Ebola-infected patients of the JIKI trial reveals concentrations lower than targeted [J].
Thi Huyen Tram Nguyen ;
Guedj, Jeremie ;
Anglaret, Xavier ;
Laouenan, Cedric ;
Madelain, Vincent ;
Taburet, Anne-Marie ;
Baize, Sylvain ;
Sissoko, Daouda ;
Pastorino, Boris ;
Rodallec, Anne ;
Piorkowski, Geraldine ;
Carazo, Sara ;
Conde, Mamoudou N. ;
Gala, Jean-Luc ;
Bore, Joseph Akoi ;
Carbonnelle, Caroline ;
Jacquot, Frederic ;
Raoul, Herve ;
Malvy, Denis ;
de lamballerie, Xavier ;
Mentre, France .
PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (02)
[5]   Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro [J].
Wang, Manli ;
Cao, Ruiyuan ;
Zhang, Leike ;
Yang, Xinglou ;
Liu, Jia ;
Xu, Mingyue ;
Shi, Zhengli ;
Hu, Zhihong ;
Zhong, Wu ;
Xiao, Gengfu .
CELL RESEARCH, 2020, 30 (03) :269-271
1